Selective Laser Trabeculoplasty
DSLT democratizes access to first-line laser for glaucoma, ocular hypertension
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.
VIDEO: Voyager direct SLT device helps improve access to glaucoma care
The Voyager direct selective laser trabeculoplasty device is now available in the U.S., according to a press release from Alcon. In this Healio Video Perspective, Zarmeena Vendal, MD, discusses her positive experience with the Voyager DSLT and its contribution to interventional glaucoma.
VIDEO: SLT may yield slower visual field progression vs. eye drops
CHICAGO — In this Healio Video Perspective from the AAO meeting, Victoria L. Tseng, MD, PhD, of the Stein Eye Institute and Doheny Eye Center at UCLA, overviews glaucoma research from a session she moderated.
VIDEO: Alcon overviews direct selective laser trabeculoplasty device, gas delivery systems
CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Alex Long of Alcon introduces some of the company’s technologies, including the Voyager direct selective laser trabeculoplasty device.
Repeat SLT ‘promising’ as first choice of treatment escalation in open-angle glaucoma
Most patients with open-angle glaucoma responded favorably to repeat selective laser trabeculoplasty, regardless of initial response, and experienced a longer duration of effect, according to a study in JAMA Ophthalmology.
Alcon acquires Belkin Vision, direct selective laser trabeculoplasty device
Alcon completed the acquisition of Belkin Vision, including its direct selective laser trabeculoplasty technology, according to a press release.
Nearly 70% of glaucoma patients reduced eye drop use after SLT
Selective laser trabeculoplasty effectively reduced IOP, as well as the quantity of eye drops used after treatment, among patients with open-angle glaucoma, according to research conducted in Brazil and published in the Journal of Glaucoma.
South Dakota expands OD practice scope to include some laser procedures, injections
On March 4, Gov. Kristi Noem signed South Dakota House Bill 1099 into law, allowing optometrists to administer some injections and perform some laser procedures.
FDA clears Eagle device for selective laser trabeculoplasty
The FDA granted 510(k) clearance for the Eagle device, a Q-switched, 532 nm-wavelength, frequency-doubled Nd:YAG glaucoma laser for selective laser trabeculoplasty, according to a press release from Belkin Vision.
SLT effective, safe as long-term treatment option for open-angle glaucoma
Selective laser trabeculoplasty can safely and effectively be used as primary intervention for treatment of open-angle glaucoma or as replacement for medications, according to a report by the American Academy of Ophthalmology.